Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios.

ABSTRACT:

Background

Bioresorbable vascular scaffolds (BVS) have become an emerging tool to treat coronary artery disease. However, the current use of BVS is still widely restricted to stable patients and non-complex lesions. In real-world practice patients are far more complex than those with simple type A lesions and the extended use of BVS to complex lesions and high-risk patients needs to be evaluated. Therefore, we sought to investigate the feasibility and performance of BVS in a broad spectrum of patients.

Methods

106 patients underwent in total 193 BVS implantations. We assessed the device-related (cardiac death, target vessel myocardial infarction, ischemia-driven target lesion revascularization) and patient-related (all-cause death, any reinfarction and any revascularization)

SUBMITTER: Jaguszewski M 

PROVIDER: S-EPMC4315475 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature